{"id":"W4410485030","doi":"10.1186/s40364-025-00784-0","title":"The progress and prospects of targeting the adenosine pathway in cancer immunotherapy","year":2025,"lang":"en","type":"review","venue":"Biomarker Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Xiangya Hospital, Central South University; Natural Science Foundation of Hunan Province; China Postdoctoral Science Foundation; Natural Science Foundation for Distinguished Young Scholars of Hunan Province; National Natural Science Foundation of China","keywords":"Adenosinergic; Medicine; Immunotherapy; Tumor microenvironment; Adenosine; Cancer immunotherapy; Adenosine receptor; Clinical trial; Cancer; Immune system; Cancer research; Bioinformatics; Oncology; Immunology; Internal medicine; Biology; Receptor; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000669606,0.0006052171,0.0009421993,0.001695343,0.0002834215,0.0009900196,0.0006485073,0.001104268,0.004306009],"category_scores_gemma":[0.0005932398,0.0002397504,0.0004823224,0.001365116,0.0003946318,0.001405794,0.0006828533,0.001895895,0.002082702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005425637,"about_ca_system_score_gemma":0.001001368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005640029,"about_ca_topic_score_gemma":0.001265203,"domain_scores_codex":[0.9998662,0.00002835976,0.00001631894,0.00002219763,0.00004758696,0.00001924955],"domain_scores_gemma":[0.9997625,0.0001226557,0.0000236539,0.000007635096,0.00005642126,0.00002729786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009396944,0.00009716942,0.00013024,0.01682178,0.00006796457,0.0002434887,0.00007138871,0.0005386994,0.003372372,0.008342662,0.02848273,0.9417374],"study_design_scores_gemma":[0.00001744402,0.0001039729,0.0004292825,0.002596841,0.00006749373,0.0006985725,0.00004433686,0.0001056173,0.0005087026,0.003463436,0.99195,0.00001427688],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001107259,0.9980769,0.000145903,0.0003561135,0.0002183991,0.000003805607,0.00001325368,0.000006279516,0.001068534],"genre_scores_gemma":[0.0005289454,0.9985458,0.0001563615,0.0001797987,0.0001596472,0.000005446814,0.00001767678,0.000001160601,0.0004051718],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004306009,"threshold_uncertainty_score":0.01440507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0687544667880343,"score_gpt":0.423567058407508,"score_spread":0.3548125916194736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}